L&C Bio Co. Ltd - Asset Resilience Ratio

Latest as of September 2025: 2.14%

L&C Bio Co. Ltd (290650) has an Asset Resilience Ratio of 2.14% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check how strategically is L&C Bio Co. Ltd's equity deployed to assess the company's strategic physical and investment asset allocation.

Liquid Assets

₩10.66 Billion

≈ $7.23 Million USD Cash + Short-term Investments

Total Assets

₩497.94 Billion

≈ $337.45 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2024)

This chart shows how L&C Bio Co. Ltd's Asset Resilience Ratio has changed over time. See L&C Bio Co. Ltd net asset quality index to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down L&C Bio Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of L&C Bio Co. Ltd.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩10.66 Billion	2.14%
Total Liquid Assets	₩10.66 Billion	2.14%

Asset Resilience Insights

Limited Liquidity: L&C Bio Co. Ltd maintains only 2.14% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

L&C Bio Co. Ltd Industry Peers by Asset Resilience Ratio

Compare L&C Bio Co. Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Medacta Group SA SW:MOVE	Medical Devices	0.86%
Double Medical Technology Inc SHE:002901	Medical Devices	12.59%
Shenzhen New Industries Biomedical SHE:300832	Medical Devices	9.95%
Jafron Biomedical Co Ltd SHE:300529	Medical Devices	39.15%
Sinocare Inc SHE:300298	Medical Devices	3.53%
Xiangyu Medical Co. Ltd. A SHG:688626	Medical Devices	1.53%
INKON Life Technology Co Ltd SHE:300143	Medical Devices	5.73%
HOB Biotech Group Corp Ltd SHG:688656	Medical Devices	2.62%

Annual Asset Resilience Ratio for L&C Bio Co. Ltd (2016–2024)

The table below shows the annual Asset Resilience Ratio data for L&C Bio Co. Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	5.08%	₩24.14 Billion ≈ $16.36 Million	₩475.60 Billion ≈ $322.31 Million	-17.50pp
2023-12-31	22.57%	₩59.19 Billion ≈ $40.11 Million	₩262.23 Billion ≈ $177.71 Million	+16.41pp
2022-12-31	6.17%	₩12.32 Billion ≈ $8.35 Million	₩199.73 Billion ≈ $135.35 Million	-12.10pp
2021-12-31	18.27%	₩19.62 Billion ≈ $13.30 Million	₩107.40 Billion ≈ $72.78 Million	-15.67pp
2020-12-31	33.94%	₩27.34 Billion ≈ $18.53 Million	₩80.58 Billion ≈ $54.60 Million	-9.72pp
2019-12-31	43.66%	₩28.91 Billion ≈ $19.59 Million	₩66.23 Billion ≈ $44.88 Million	-20.10pp
2018-12-31	63.76%	₩36.58 Billion ≈ $24.79 Million	₩57.38 Billion ≈ $38.88 Million	+31.65pp
2017-12-31	32.11%	₩6.58 Billion ≈ $4.46 Million	₩20.49 Billion ≈ $13.89 Million	+7.35pp
2016-12-31	24.76%	₩3.88 Billion ≈ $2.63 Million	₩15.66 Billion ≈ $10.61 Million	--

pp = percentage points

About L&C Bio Co. Ltd

KQ:290650 Korea Medical Devices

Market Cap

$1.34 Billion

₩1.97 Trillion KRW

Market Cap Rank

#7832 Global

#210 in Korea

Share Price

₩80200.00

Change (1 day)

-7.07%

52-Week Range

₩26800.00 - ₩118300.00

All Time High

₩118300.00